Easton Pharmaceuticals, Inc. Common Stock

1D
1W
1M
3M
YTD
1Y
5Y
ALL

Why Robinhood?

You can watch EAPH and buy or sell other stocks, ETFs, and their options commission-free!

About EAPH

Easton Pharmaceuticals, Inc. engages in the design, development, and marketing of drugs, therapeutic, and cosmetic healthcare products. It owns wound-healing drug and topically delivered drugs to treat cancer and other therapeutic products. 

CEO
Evan Karras
CEOEvan Karras
Employees
Employees
Headquarters
Toronto, Ontario
HeadquartersToronto, Ontario
Founded
1997
Founded1997
Employees
Employees

EAPH Key Statistics

Market cap
0.00
Market cap0.00
Price-Earnings ratio
Price-Earnings ratio
Dividend yield
Dividend yield
Average volume
48.51K
Average volume48.51K
High today
High today
Low today
Low today
Open price
Open price
Volume
10.00K
Volume10.00K
52 Week high
$0.0001
52 Week high$0.0001
52 Week low
$0.00
52 Week low$0.00

Stock Snapshot

Easton Pharmaceuticals, Inc. Common Stock(EAPH) stock is priced at $0.00, giving the company a market capitalization of 0.

During the trading day, Easton Pharmaceuticals, Inc. Common Stock(EAPH) stock saw an opening price of —, a peak of —, and a bottom of —.

Trading activity shows a volume of 10K, compared to an average daily volume of 48.51K.

Over the past 52 weeks, Easton Pharmaceuticals, Inc. Common Stock(EAPH) stock has traded between a high of $0.00 and a low of $0.00.

Over the past 52 weeks, Easton Pharmaceuticals, Inc. Common Stock(EAPH) stock has traded between a high of $0.00 and a low of $0.00.

Popular Stocks

This list is generated by looking at the top 100 stocks and ETFs most commonly held by Robinhood customers and showing a random subset

Newly Listed

This list is generated by showing companies that recently went public.

All investments involve risks, including the loss of principal. Securities trading offered through Robinhood Financial LLC, Member SIPC and a registered broker-dealer. Options are risky and aren’t suitable for all investors. To learn more about risks, read the Options Disclosure Document.